Global Finasteride (Oral Route) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Finasteride (Oral Route) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Finasteride, when taken orally, is a medication used to treat symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate. It is also prescribed to treat male pattern hair loss (androgenetic alopecia) in men. Finasteride works by inhibiting the action of the enzyme 5-alpha reductase, which converts the male hormone testosterone to dihydrotestosterone (DHT). By reducing DHT levels in the body, finasteride helps to shrink the prostate and promote hair regrowth in men with male pattern baldness. It is important to note that finasteride should only be taken as prescribed by a healthcare provider, as it can have side effects and may not be suitable for everyone.
The Global Info Research report includes an overview of the development of the Finasteride (Oral Route) industry chain, the market status of Urology (1mg, 5mg), Dermatology (1mg, 5mg), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Finasteride (Oral Route).
Regionally, the report analyzes the Finasteride (Oral Route) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Finasteride (Oral Route) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Finasteride (Oral Route) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Finasteride (Oral Route) industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Pcs), revenue generated, and market share of different by Type (e.g., 1mg, 5mg).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Finasteride (Oral Route) market.
Regional Analysis: The report involves examining the Finasteride (Oral Route) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Finasteride (Oral Route) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Finasteride (Oral Route):
Company Analysis: Report covers individual Finasteride (Oral Route) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Finasteride (Oral Route) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Urology, Dermatology).
Technology Analysis: Report covers specific technologies relevant to Finasteride (Oral Route). It assesses the current state, advancements, and potential future developments in Finasteride (Oral Route) areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Finasteride (Oral Route) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Finasteride (Oral Route) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Finasteride (Oral Route) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Finasteride (Oral Route), with price, sales, revenue and global market share of Finasteride (Oral Route) from 2019 to 2024.
Chapter 3, the Finasteride (Oral Route) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Finasteride (Oral Route) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Finasteride (Oral Route) market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Finasteride (Oral Route).
Chapter 14 and 15, to describe Finasteride (Oral Route) sales channel, distributors, customers, research findings and conclusion.
Finasteride, when taken orally, is a medication used to treat symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate. It is also prescribed to treat male pattern hair loss (androgenetic alopecia) in men. Finasteride works by inhibiting the action of the enzyme 5-alpha reductase, which converts the male hormone testosterone to dihydrotestosterone (DHT). By reducing DHT levels in the body, finasteride helps to shrink the prostate and promote hair regrowth in men with male pattern baldness. It is important to note that finasteride should only be taken as prescribed by a healthcare provider, as it can have side effects and may not be suitable for everyone.
The Global Info Research report includes an overview of the development of the Finasteride (Oral Route) industry chain, the market status of Urology (1mg, 5mg), Dermatology (1mg, 5mg), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Finasteride (Oral Route).
Regionally, the report analyzes the Finasteride (Oral Route) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Finasteride (Oral Route) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Finasteride (Oral Route) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Finasteride (Oral Route) industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Pcs), revenue generated, and market share of different by Type (e.g., 1mg, 5mg).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Finasteride (Oral Route) market.
Regional Analysis: The report involves examining the Finasteride (Oral Route) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Finasteride (Oral Route) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Finasteride (Oral Route):
Company Analysis: Report covers individual Finasteride (Oral Route) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Finasteride (Oral Route) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Urology, Dermatology).
Technology Analysis: Report covers specific technologies relevant to Finasteride (Oral Route). It assesses the current state, advancements, and potential future developments in Finasteride (Oral Route) areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Finasteride (Oral Route) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Finasteride (Oral Route) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- 1mg
- 5mg
- Urology
- Dermatology
- Merck
- Sandoz
- Actavis
- Cipla
- RelonChem
- Dr. Reddy
- Accord Pharmaceuticals
- Hangzhou Kangenbei Pharmaceutical Co., Ltd
- Hunan Zhengqing Pharmaceutical Group Co., Ltd
- Tianfang Pharmaceutical Co., Ltd
- Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd
- Zhejiang Xianju Pharmaceutical Co., Ltd
- Shanghai Hyundai Pharmaceutical Co., Ltd
- Hunan Baicao Pharmaceutical Co., Ltd
- Guangdong Yishu Pharmaceutical Co., Ltd
- CR SECCO Pharmaceutical Co., Ltd
- Shanghai Xinya Pharmaceutical Minhang Co., Ltd
- Renhetang Pharmaceutical Company Limited
- Runenberg Pharmaceuticals Ltd
- Nanjing Shenghe Pharmaceutical Co., Ltd
- Nanjing Sea Whale Pharmaceutical Co., Ltd
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Finasteride (Oral Route) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Finasteride (Oral Route), with price, sales, revenue and global market share of Finasteride (Oral Route) from 2019 to 2024.
Chapter 3, the Finasteride (Oral Route) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Finasteride (Oral Route) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Finasteride (Oral Route) market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Finasteride (Oral Route).
Chapter 14 and 15, to describe Finasteride (Oral Route) sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Finasteride (Oral Route)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Finasteride (Oral Route) Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 1mg
1.3.3 5mg
1.4 Market Analysis by Application
1.4.1 Overview: Global Finasteride (Oral Route) Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Urology
1.4.3 Dermatology
1.5 Global Finasteride (Oral Route) Market Size & Forecast
1.5.1 Global Finasteride (Oral Route) Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Finasteride (Oral Route) Sales Quantity (2019-2030)
1.5.3 Global Finasteride (Oral Route) Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Finasteride (Oral Route) Product and Services
2.1.4 Merck Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Merck Recent Developments/Updates
2.2 Sandoz
2.2.1 Sandoz Details
2.2.2 Sandoz Major Business
2.2.3 Sandoz Finasteride (Oral Route) Product and Services
2.2.4 Sandoz Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sandoz Recent Developments/Updates
2.3 Actavis
2.3.1 Actavis Details
2.3.2 Actavis Major Business
2.3.3 Actavis Finasteride (Oral Route) Product and Services
2.3.4 Actavis Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Actavis Recent Developments/Updates
2.4 Cipla
2.4.1 Cipla Details
2.4.2 Cipla Major Business
2.4.3 Cipla Finasteride (Oral Route) Product and Services
2.4.4 Cipla Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Cipla Recent Developments/Updates
2.5 RelonChem
2.5.1 RelonChem Details
2.5.2 RelonChem Major Business
2.5.3 RelonChem Finasteride (Oral Route) Product and Services
2.5.4 RelonChem Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 RelonChem Recent Developments/Updates
2.6 Dr. Reddy
2.6.1 Dr. Reddy Details
2.6.2 Dr. Reddy Major Business
2.6.3 Dr. Reddy Finasteride (Oral Route) Product and Services
2.6.4 Dr. Reddy Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Dr. Reddy Recent Developments/Updates
2.7 Accord Pharmaceuticals
2.7.1 Accord Pharmaceuticals Details
2.7.2 Accord Pharmaceuticals Major Business
2.7.3 Accord Pharmaceuticals Finasteride (Oral Route) Product and Services
2.7.4 Accord Pharmaceuticals Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Accord Pharmaceuticals Recent Developments/Updates
2.8 Hangzhou Kangenbei Pharmaceutical Co., Ltd
2.8.1 Hangzhou Kangenbei Pharmaceutical Co., Ltd Details
2.8.2 Hangzhou Kangenbei Pharmaceutical Co., Ltd Major Business
2.8.3 Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
2.8.4 Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Hangzhou Kangenbei Pharmaceutical Co., Ltd Recent Developments/Updates
2.9 Hunan Zhengqing Pharmaceutical Group Co., Ltd
2.9.1 Hunan Zhengqing Pharmaceutical Group Co., Ltd Details
2.9.2 Hunan Zhengqing Pharmaceutical Group Co., Ltd Major Business
2.9.3 Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Product and Services
2.9.4 Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Hunan Zhengqing Pharmaceutical Group Co., Ltd Recent Developments/Updates
2.10 Tianfang Pharmaceutical Co., Ltd
2.10.1 Tianfang Pharmaceutical Co., Ltd Details
2.10.2 Tianfang Pharmaceutical Co., Ltd Major Business
2.10.3 Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
2.10.4 Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Tianfang Pharmaceutical Co., Ltd Recent Developments/Updates
2.11 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd
2.11.1 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Details
2.11.2 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Major Business
2.11.3 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
2.11.4 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Recent Developments/Updates
2.12 Zhejiang Xianju Pharmaceutical Co., Ltd
2.12.1 Zhejiang Xianju Pharmaceutical Co., Ltd Details
2.12.2 Zhejiang Xianju Pharmaceutical Co., Ltd Major Business
2.12.3 Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
2.12.4 Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Zhejiang Xianju Pharmaceutical Co., Ltd Recent Developments/Updates
2.13 Shanghai Hyundai Pharmaceutical Co., Ltd
2.13.1 Shanghai Hyundai Pharmaceutical Co., Ltd Details
2.13.2 Shanghai Hyundai Pharmaceutical Co., Ltd Major Business
2.13.3 Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
2.13.4 Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Shanghai Hyundai Pharmaceutical Co., Ltd Recent Developments/Updates
2.14 Hunan Baicao Pharmaceutical Co., Ltd
2.14.1 Hunan Baicao Pharmaceutical Co., Ltd Details
2.14.2 Hunan Baicao Pharmaceutical Co., Ltd Major Business
2.14.3 Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
2.14.4 Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Hunan Baicao Pharmaceutical Co., Ltd Recent Developments/Updates
2.15 Guangdong Yishu Pharmaceutical Co., Ltd
2.15.1 Guangdong Yishu Pharmaceutical Co., Ltd Details
2.15.2 Guangdong Yishu Pharmaceutical Co., Ltd Major Business
2.15.3 Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
2.15.4 Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Guangdong Yishu Pharmaceutical Co., Ltd Recent Developments/Updates
2.16 CR SECCO Pharmaceutical Co., Ltd
2.16.1 CR SECCO Pharmaceutical Co., Ltd Details
2.16.2 CR SECCO Pharmaceutical Co., Ltd Major Business
2.16.3 CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
2.16.4 CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 CR SECCO Pharmaceutical Co., Ltd Recent Developments/Updates
2.17 Shanghai Xinya Pharmaceutical Minhang Co., Ltd
2.17.1 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Details
2.17.2 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Major Business
2.17.3 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Product and Services
2.17.4 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Recent Developments/Updates
2.18 Renhetang Pharmaceutical Company Limited
2.18.1 Renhetang Pharmaceutical Company Limited Details
2.18.2 Renhetang Pharmaceutical Company Limited Major Business
2.18.3 Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Product and Services
2.18.4 Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Renhetang Pharmaceutical Company Limited Recent Developments/Updates
2.19 Runenberg Pharmaceuticals Ltd
2.19.1 Runenberg Pharmaceuticals Ltd Details
2.19.2 Runenberg Pharmaceuticals Ltd Major Business
2.19.3 Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Product and Services
2.19.4 Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Runenberg Pharmaceuticals Ltd Recent Developments/Updates
2.20 Nanjing Shenghe Pharmaceutical Co., Ltd
2.20.1 Nanjing Shenghe Pharmaceutical Co., Ltd Details
2.20.2 Nanjing Shenghe Pharmaceutical Co., Ltd Major Business
2.20.3 Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
2.20.4 Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Nanjing Shenghe Pharmaceutical Co., Ltd Recent Developments/Updates
2.21 Nanjing Sea Whale Pharmaceutical Co., Ltd
2.21.1 Nanjing Sea Whale Pharmaceutical Co., Ltd Details
2.21.2 Nanjing Sea Whale Pharmaceutical Co., Ltd Major Business
2.21.3 Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
2.21.4 Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Nanjing Sea Whale Pharmaceutical Co., Ltd Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: FINASTERIDE (ORAL ROUTE) BY MANUFACTURER
3.1 Global Finasteride (Oral Route) Sales Quantity by Manufacturer (2019-2024)
3.2 Global Finasteride (Oral Route) Revenue by Manufacturer (2019-2024)
3.3 Global Finasteride (Oral Route) Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Finasteride (Oral Route) by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Finasteride (Oral Route) Manufacturer Market Share in 2023
3.4.2 Top 6 Finasteride (Oral Route) Manufacturer Market Share in 2023
3.5 Finasteride (Oral Route) Market: Overall Company Footprint Analysis
3.5.1 Finasteride (Oral Route) Market: Region Footprint
3.5.2 Finasteride (Oral Route) Market: Company Product Type Footprint
3.5.3 Finasteride (Oral Route) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Finasteride (Oral Route) Market Size by Region
4.1.1 Global Finasteride (Oral Route) Sales Quantity by Region (2019-2030)
4.1.2 Global Finasteride (Oral Route) Consumption Value by Region (2019-2030)
4.1.3 Global Finasteride (Oral Route) Average Price by Region (2019-2030)
4.2 North America Finasteride (Oral Route) Consumption Value (2019-2030)
4.3 Europe Finasteride (Oral Route) Consumption Value (2019-2030)
4.4 Asia-Pacific Finasteride (Oral Route) Consumption Value (2019-2030)
4.5 South America Finasteride (Oral Route) Consumption Value (2019-2030)
4.6 Middle East and Africa Finasteride (Oral Route) Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Finasteride (Oral Route) Sales Quantity by Type (2019-2030)
5.2 Global Finasteride (Oral Route) Consumption Value by Type (2019-2030)
5.3 Global Finasteride (Oral Route) Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Finasteride (Oral Route) Sales Quantity by Application (2019-2030)
6.2 Global Finasteride (Oral Route) Consumption Value by Application (2019-2030)
6.3 Global Finasteride (Oral Route) Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Finasteride (Oral Route) Sales Quantity by Type (2019-2030)
7.2 North America Finasteride (Oral Route) Sales Quantity by Application (2019-2030)
7.3 North America Finasteride (Oral Route) Market Size by Country
7.3.1 North America Finasteride (Oral Route) Sales Quantity by Country (2019-2030)
7.3.2 North America Finasteride (Oral Route) Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Finasteride (Oral Route) Sales Quantity by Type (2019-2030)
8.2 Europe Finasteride (Oral Route) Sales Quantity by Application (2019-2030)
8.3 Europe Finasteride (Oral Route) Market Size by Country
8.3.1 Europe Finasteride (Oral Route) Sales Quantity by Country (2019-2030)
8.3.2 Europe Finasteride (Oral Route) Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Finasteride (Oral Route) Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Finasteride (Oral Route) Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Finasteride (Oral Route) Market Size by Region
9.3.1 Asia-Pacific Finasteride (Oral Route) Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Finasteride (Oral Route) Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Finasteride (Oral Route) Sales Quantity by Type (2019-2030)
10.2 South America Finasteride (Oral Route) Sales Quantity by Application (2019-2030)
10.3 South America Finasteride (Oral Route) Market Size by Country
10.3.1 South America Finasteride (Oral Route) Sales Quantity by Country (2019-2030)
10.3.2 South America Finasteride (Oral Route) Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Finasteride (Oral Route) Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Finasteride (Oral Route) Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Finasteride (Oral Route) Market Size by Country
11.3.1 Middle East & Africa Finasteride (Oral Route) Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Finasteride (Oral Route) Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Finasteride (Oral Route) Market Drivers
12.2 Finasteride (Oral Route) Market Restraints
12.3 Finasteride (Oral Route) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Finasteride (Oral Route) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Finasteride (Oral Route)
13.3 Finasteride (Oral Route) Production Process
13.4 Finasteride (Oral Route) Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Finasteride (Oral Route) Typical Distributors
14.3 Finasteride (Oral Route) Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Finasteride (Oral Route)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Finasteride (Oral Route) Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 1mg
1.3.3 5mg
1.4 Market Analysis by Application
1.4.1 Overview: Global Finasteride (Oral Route) Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Urology
1.4.3 Dermatology
1.5 Global Finasteride (Oral Route) Market Size & Forecast
1.5.1 Global Finasteride (Oral Route) Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Finasteride (Oral Route) Sales Quantity (2019-2030)
1.5.3 Global Finasteride (Oral Route) Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Finasteride (Oral Route) Product and Services
2.1.4 Merck Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Merck Recent Developments/Updates
2.2 Sandoz
2.2.1 Sandoz Details
2.2.2 Sandoz Major Business
2.2.3 Sandoz Finasteride (Oral Route) Product and Services
2.2.4 Sandoz Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sandoz Recent Developments/Updates
2.3 Actavis
2.3.1 Actavis Details
2.3.2 Actavis Major Business
2.3.3 Actavis Finasteride (Oral Route) Product and Services
2.3.4 Actavis Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Actavis Recent Developments/Updates
2.4 Cipla
2.4.1 Cipla Details
2.4.2 Cipla Major Business
2.4.3 Cipla Finasteride (Oral Route) Product and Services
2.4.4 Cipla Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Cipla Recent Developments/Updates
2.5 RelonChem
2.5.1 RelonChem Details
2.5.2 RelonChem Major Business
2.5.3 RelonChem Finasteride (Oral Route) Product and Services
2.5.4 RelonChem Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 RelonChem Recent Developments/Updates
2.6 Dr. Reddy
2.6.1 Dr. Reddy Details
2.6.2 Dr. Reddy Major Business
2.6.3 Dr. Reddy Finasteride (Oral Route) Product and Services
2.6.4 Dr. Reddy Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Dr. Reddy Recent Developments/Updates
2.7 Accord Pharmaceuticals
2.7.1 Accord Pharmaceuticals Details
2.7.2 Accord Pharmaceuticals Major Business
2.7.3 Accord Pharmaceuticals Finasteride (Oral Route) Product and Services
2.7.4 Accord Pharmaceuticals Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Accord Pharmaceuticals Recent Developments/Updates
2.8 Hangzhou Kangenbei Pharmaceutical Co., Ltd
2.8.1 Hangzhou Kangenbei Pharmaceutical Co., Ltd Details
2.8.2 Hangzhou Kangenbei Pharmaceutical Co., Ltd Major Business
2.8.3 Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
2.8.4 Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Hangzhou Kangenbei Pharmaceutical Co., Ltd Recent Developments/Updates
2.9 Hunan Zhengqing Pharmaceutical Group Co., Ltd
2.9.1 Hunan Zhengqing Pharmaceutical Group Co., Ltd Details
2.9.2 Hunan Zhengqing Pharmaceutical Group Co., Ltd Major Business
2.9.3 Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Product and Services
2.9.4 Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Hunan Zhengqing Pharmaceutical Group Co., Ltd Recent Developments/Updates
2.10 Tianfang Pharmaceutical Co., Ltd
2.10.1 Tianfang Pharmaceutical Co., Ltd Details
2.10.2 Tianfang Pharmaceutical Co., Ltd Major Business
2.10.3 Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
2.10.4 Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Tianfang Pharmaceutical Co., Ltd Recent Developments/Updates
2.11 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd
2.11.1 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Details
2.11.2 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Major Business
2.11.3 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
2.11.4 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Recent Developments/Updates
2.12 Zhejiang Xianju Pharmaceutical Co., Ltd
2.12.1 Zhejiang Xianju Pharmaceutical Co., Ltd Details
2.12.2 Zhejiang Xianju Pharmaceutical Co., Ltd Major Business
2.12.3 Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
2.12.4 Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Zhejiang Xianju Pharmaceutical Co., Ltd Recent Developments/Updates
2.13 Shanghai Hyundai Pharmaceutical Co., Ltd
2.13.1 Shanghai Hyundai Pharmaceutical Co., Ltd Details
2.13.2 Shanghai Hyundai Pharmaceutical Co., Ltd Major Business
2.13.3 Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
2.13.4 Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Shanghai Hyundai Pharmaceutical Co., Ltd Recent Developments/Updates
2.14 Hunan Baicao Pharmaceutical Co., Ltd
2.14.1 Hunan Baicao Pharmaceutical Co., Ltd Details
2.14.2 Hunan Baicao Pharmaceutical Co., Ltd Major Business
2.14.3 Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
2.14.4 Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Hunan Baicao Pharmaceutical Co., Ltd Recent Developments/Updates
2.15 Guangdong Yishu Pharmaceutical Co., Ltd
2.15.1 Guangdong Yishu Pharmaceutical Co., Ltd Details
2.15.2 Guangdong Yishu Pharmaceutical Co., Ltd Major Business
2.15.3 Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
2.15.4 Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Guangdong Yishu Pharmaceutical Co., Ltd Recent Developments/Updates
2.16 CR SECCO Pharmaceutical Co., Ltd
2.16.1 CR SECCO Pharmaceutical Co., Ltd Details
2.16.2 CR SECCO Pharmaceutical Co., Ltd Major Business
2.16.3 CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
2.16.4 CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 CR SECCO Pharmaceutical Co., Ltd Recent Developments/Updates
2.17 Shanghai Xinya Pharmaceutical Minhang Co., Ltd
2.17.1 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Details
2.17.2 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Major Business
2.17.3 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Product and Services
2.17.4 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Recent Developments/Updates
2.18 Renhetang Pharmaceutical Company Limited
2.18.1 Renhetang Pharmaceutical Company Limited Details
2.18.2 Renhetang Pharmaceutical Company Limited Major Business
2.18.3 Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Product and Services
2.18.4 Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Renhetang Pharmaceutical Company Limited Recent Developments/Updates
2.19 Runenberg Pharmaceuticals Ltd
2.19.1 Runenberg Pharmaceuticals Ltd Details
2.19.2 Runenberg Pharmaceuticals Ltd Major Business
2.19.3 Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Product and Services
2.19.4 Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Runenberg Pharmaceuticals Ltd Recent Developments/Updates
2.20 Nanjing Shenghe Pharmaceutical Co., Ltd
2.20.1 Nanjing Shenghe Pharmaceutical Co., Ltd Details
2.20.2 Nanjing Shenghe Pharmaceutical Co., Ltd Major Business
2.20.3 Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
2.20.4 Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Nanjing Shenghe Pharmaceutical Co., Ltd Recent Developments/Updates
2.21 Nanjing Sea Whale Pharmaceutical Co., Ltd
2.21.1 Nanjing Sea Whale Pharmaceutical Co., Ltd Details
2.21.2 Nanjing Sea Whale Pharmaceutical Co., Ltd Major Business
2.21.3 Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
2.21.4 Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Nanjing Sea Whale Pharmaceutical Co., Ltd Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: FINASTERIDE (ORAL ROUTE) BY MANUFACTURER
3.1 Global Finasteride (Oral Route) Sales Quantity by Manufacturer (2019-2024)
3.2 Global Finasteride (Oral Route) Revenue by Manufacturer (2019-2024)
3.3 Global Finasteride (Oral Route) Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Finasteride (Oral Route) by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Finasteride (Oral Route) Manufacturer Market Share in 2023
3.4.2 Top 6 Finasteride (Oral Route) Manufacturer Market Share in 2023
3.5 Finasteride (Oral Route) Market: Overall Company Footprint Analysis
3.5.1 Finasteride (Oral Route) Market: Region Footprint
3.5.2 Finasteride (Oral Route) Market: Company Product Type Footprint
3.5.3 Finasteride (Oral Route) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Finasteride (Oral Route) Market Size by Region
4.1.1 Global Finasteride (Oral Route) Sales Quantity by Region (2019-2030)
4.1.2 Global Finasteride (Oral Route) Consumption Value by Region (2019-2030)
4.1.3 Global Finasteride (Oral Route) Average Price by Region (2019-2030)
4.2 North America Finasteride (Oral Route) Consumption Value (2019-2030)
4.3 Europe Finasteride (Oral Route) Consumption Value (2019-2030)
4.4 Asia-Pacific Finasteride (Oral Route) Consumption Value (2019-2030)
4.5 South America Finasteride (Oral Route) Consumption Value (2019-2030)
4.6 Middle East and Africa Finasteride (Oral Route) Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Finasteride (Oral Route) Sales Quantity by Type (2019-2030)
5.2 Global Finasteride (Oral Route) Consumption Value by Type (2019-2030)
5.3 Global Finasteride (Oral Route) Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Finasteride (Oral Route) Sales Quantity by Application (2019-2030)
6.2 Global Finasteride (Oral Route) Consumption Value by Application (2019-2030)
6.3 Global Finasteride (Oral Route) Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Finasteride (Oral Route) Sales Quantity by Type (2019-2030)
7.2 North America Finasteride (Oral Route) Sales Quantity by Application (2019-2030)
7.3 North America Finasteride (Oral Route) Market Size by Country
7.3.1 North America Finasteride (Oral Route) Sales Quantity by Country (2019-2030)
7.3.2 North America Finasteride (Oral Route) Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Finasteride (Oral Route) Sales Quantity by Type (2019-2030)
8.2 Europe Finasteride (Oral Route) Sales Quantity by Application (2019-2030)
8.3 Europe Finasteride (Oral Route) Market Size by Country
8.3.1 Europe Finasteride (Oral Route) Sales Quantity by Country (2019-2030)
8.3.2 Europe Finasteride (Oral Route) Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Finasteride (Oral Route) Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Finasteride (Oral Route) Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Finasteride (Oral Route) Market Size by Region
9.3.1 Asia-Pacific Finasteride (Oral Route) Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Finasteride (Oral Route) Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Finasteride (Oral Route) Sales Quantity by Type (2019-2030)
10.2 South America Finasteride (Oral Route) Sales Quantity by Application (2019-2030)
10.3 South America Finasteride (Oral Route) Market Size by Country
10.3.1 South America Finasteride (Oral Route) Sales Quantity by Country (2019-2030)
10.3.2 South America Finasteride (Oral Route) Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Finasteride (Oral Route) Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Finasteride (Oral Route) Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Finasteride (Oral Route) Market Size by Country
11.3.1 Middle East & Africa Finasteride (Oral Route) Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Finasteride (Oral Route) Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Finasteride (Oral Route) Market Drivers
12.2 Finasteride (Oral Route) Market Restraints
12.3 Finasteride (Oral Route) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Finasteride (Oral Route) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Finasteride (Oral Route)
13.3 Finasteride (Oral Route) Production Process
13.4 Finasteride (Oral Route) Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Finasteride (Oral Route) Typical Distributors
14.3 Finasteride (Oral Route) Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Finasteride (Oral Route) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Finasteride (Oral Route) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Finasteride (Oral Route) Product and Services
Table 6. Merck Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Merck Recent Developments/Updates
Table 8. Sandoz Basic Information, Manufacturing Base and Competitors
Table 9. Sandoz Major Business
Table 10. Sandoz Finasteride (Oral Route) Product and Services
Table 11. Sandoz Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Sandoz Recent Developments/Updates
Table 13. Actavis Basic Information, Manufacturing Base and Competitors
Table 14. Actavis Major Business
Table 15. Actavis Finasteride (Oral Route) Product and Services
Table 16. Actavis Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Actavis Recent Developments/Updates
Table 18. Cipla Basic Information, Manufacturing Base and Competitors
Table 19. Cipla Major Business
Table 20. Cipla Finasteride (Oral Route) Product and Services
Table 21. Cipla Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Cipla Recent Developments/Updates
Table 23. RelonChem Basic Information, Manufacturing Base and Competitors
Table 24. RelonChem Major Business
Table 25. RelonChem Finasteride (Oral Route) Product and Services
Table 26. RelonChem Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. RelonChem Recent Developments/Updates
Table 28. Dr. Reddy Basic Information, Manufacturing Base and Competitors
Table 29. Dr. Reddy Major Business
Table 30. Dr. Reddy Finasteride (Oral Route) Product and Services
Table 31. Dr. Reddy Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Dr. Reddy Recent Developments/Updates
Table 33. Accord Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 34. Accord Pharmaceuticals Major Business
Table 35. Accord Pharmaceuticals Finasteride (Oral Route) Product and Services
Table 36. Accord Pharmaceuticals Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Accord Pharmaceuticals Recent Developments/Updates
Table 38. Hangzhou Kangenbei Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 39. Hangzhou Kangenbei Pharmaceutical Co., Ltd Major Business
Table 40. Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 41. Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Hangzhou Kangenbei Pharmaceutical Co., Ltd Recent Developments/Updates
Table 43. Hunan Zhengqing Pharmaceutical Group Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 44. Hunan Zhengqing Pharmaceutical Group Co., Ltd Major Business
Table 45. Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Product and Services
Table 46. Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Hunan Zhengqing Pharmaceutical Group Co., Ltd Recent Developments/Updates
Table 48. Tianfang Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 49. Tianfang Pharmaceutical Co., Ltd Major Business
Table 50. Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 51. Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Tianfang Pharmaceutical Co., Ltd Recent Developments/Updates
Table 53. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 54. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Major Business
Table 55. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 56. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Recent Developments/Updates
Table 58. Zhejiang Xianju Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 59. Zhejiang Xianju Pharmaceutical Co., Ltd Major Business
Table 60. Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 61. Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Zhejiang Xianju Pharmaceutical Co., Ltd Recent Developments/Updates
Table 63. Shanghai Hyundai Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 64. Shanghai Hyundai Pharmaceutical Co., Ltd Major Business
Table 65. Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 66. Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Shanghai Hyundai Pharmaceutical Co., Ltd Recent Developments/Updates
Table 68. Hunan Baicao Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 69. Hunan Baicao Pharmaceutical Co., Ltd Major Business
Table 70. Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 71. Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Hunan Baicao Pharmaceutical Co., Ltd Recent Developments/Updates
Table 73. Guangdong Yishu Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 74. Guangdong Yishu Pharmaceutical Co., Ltd Major Business
Table 75. Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 76. Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Guangdong Yishu Pharmaceutical Co., Ltd Recent Developments/Updates
Table 78. CR SECCO Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 79. CR SECCO Pharmaceutical Co., Ltd Major Business
Table 80. CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 81. CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. CR SECCO Pharmaceutical Co., Ltd Recent Developments/Updates
Table 83. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 84. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Major Business
Table 85. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Product and Services
Table 86. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Recent Developments/Updates
Table 88. Renhetang Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 89. Renhetang Pharmaceutical Company Limited Major Business
Table 90. Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Product and Services
Table 91. Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Renhetang Pharmaceutical Company Limited Recent Developments/Updates
Table 93. Runenberg Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors
Table 94. Runenberg Pharmaceuticals Ltd Major Business
Table 95. Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Product and Services
Table 96. Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. Runenberg Pharmaceuticals Ltd Recent Developments/Updates
Table 98. Nanjing Shenghe Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 99. Nanjing Shenghe Pharmaceutical Co., Ltd Major Business
Table 100. Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 101. Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 102. Nanjing Shenghe Pharmaceutical Co., Ltd Recent Developments/Updates
Table 103. Nanjing Sea Whale Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Nanjing Sea Whale Pharmaceutical Co., Ltd Major Business
Table 105. Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 106. Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Nanjing Sea Whale Pharmaceutical Co., Ltd Recent Developments/Updates
Table 108. Global Finasteride (Oral Route) Sales Quantity by Manufacturer (2019-2024) & (K Pcs)
Table 109. Global Finasteride (Oral Route) Revenue by Manufacturer (2019-2024) & (USD Million)
Table 110. Global Finasteride (Oral Route) Average Price by Manufacturer (2019-2024) & (US$/Pcs)
Table 111. Market Position of Manufacturers in Finasteride (Oral Route), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 112. Head Office and Finasteride (Oral Route) Production Site of Key Manufacturer
Table 113. Finasteride (Oral Route) Market: Company Product Type Footprint
Table 114. Finasteride (Oral Route) Market: Company Product Application Footprint
Table 115. Finasteride (Oral Route) New Market Entrants and Barriers to Market Entry
Table 116. Finasteride (Oral Route) Mergers, Acquisition, Agreements, and Collaborations
Table 117. Global Finasteride (Oral Route) Sales Quantity by Region (2019-2024) & (K Pcs)
Table 118. Global Finasteride (Oral Route) Sales Quantity by Region (2025-2030) & (K Pcs)
Table 119. Global Finasteride (Oral Route) Consumption Value by Region (2019-2024) & (USD Million)
Table 120. Global Finasteride (Oral Route) Consumption Value by Region (2025-2030) & (USD Million)
Table 121. Global Finasteride (Oral Route) Average Price by Region (2019-2024) & (US$/Pcs)
Table 122. Global Finasteride (Oral Route) Average Price by Region (2025-2030) & (US$/Pcs)
Table 123. Global Finasteride (Oral Route) Sales Quantity by Type (2019-2024) & (K Pcs)
Table 124. Global Finasteride (Oral Route) Sales Quantity by Type (2025-2030) & (K Pcs)
Table 125. Global Finasteride (Oral Route) Consumption Value by Type (2019-2024) & (USD Million)
Table 126. Global Finasteride (Oral Route) Consumption Value by Type (2025-2030) & (USD Million)
Table 127. Global Finasteride (Oral Route) Average Price by Type (2019-2024) & (US$/Pcs)
Table 128. Global Finasteride (Oral Route) Average Price by Type (2025-2030) & (US$/Pcs)
Table 129. Global Finasteride (Oral Route) Sales Quantity by Application (2019-2024) & (K Pcs)
Table 130. Global Finasteride (Oral Route) Sales Quantity by Application (2025-2030) & (K Pcs)
Table 131. Global Finasteride (Oral Route) Consumption Value by Application (2019-2024) & (USD Million)
Table 132. Global Finasteride (Oral Route) Consumption Value by Application (2025-2030) & (USD Million)
Table 133. Global Finasteride (Oral Route) Average Price by Application (2019-2024) & (US$/Pcs)
Table 134. Global Finasteride (Oral Route) Average Price by Application (2025-2030) & (US$/Pcs)
Table 135. North America Finasteride (Oral Route) Sales Quantity by Type (2019-2024) & (K Pcs)
Table 136. North America Finasteride (Oral Route) Sales Quantity by Type (2025-2030) & (K Pcs)
Table 137. North America Finasteride (Oral Route) Sales Quantity by Application (2019-2024) & (K Pcs)
Table 138. North America Finasteride (Oral Route) Sales Quantity by Application (2025-2030) & (K Pcs)
Table 139. North America Finasteride (Oral Route) Sales Quantity by Country (2019-2024) & (K Pcs)
Table 140. North America Finasteride (Oral Route) Sales Quantity by Country (2025-2030) & (K Pcs)
Table 141. North America Finasteride (Oral Route) Consumption Value by Country (2019-2024) & (USD Million)
Table 142. North America Finasteride (Oral Route) Consumption Value by Country (2025-2030) & (USD Million)
Table 143. Europe Finasteride (Oral Route) Sales Quantity by Type (2019-2024) & (K Pcs)
Table 144. Europe Finasteride (Oral Route) Sales Quantity by Type (2025-2030) & (K Pcs)
Table 145. Europe Finasteride (Oral Route) Sales Quantity by Application (2019-2024) & (K Pcs)
Table 146. Europe Finasteride (Oral Route) Sales Quantity by Application (2025-2030) & (K Pcs)
Table 147. Europe Finasteride (Oral Route) Sales Quantity by Country (2019-2024) & (K Pcs)
Table 148. Europe Finasteride (Oral Route) Sales Quantity by Country (2025-2030) & (K Pcs)
Table 149. Europe Finasteride (Oral Route) Consumption Value by Country (2019-2024) & (USD Million)
Table 150. Europe Finasteride (Oral Route) Consumption Value by Country (2025-2030) & (USD Million)
Table 151. Asia-Pacific Finasteride (Oral Route) Sales Quantity by Type (2019-2024) & (K Pcs)
Table 152. Asia-Pacific Finasteride (Oral Route) Sales Quantity by Type (2025-2030) & (K Pcs)
Table 153. Asia-Pacific Finasteride (Oral Route) Sales Quantity by Application (2019-2024) & (K Pcs)
Table 154. Asia-Pacific Finasteride (Oral Route) Sales Quantity by Application (2025-2030) & (K Pcs)
Table 155. Asia-Pacific Finasteride (Oral Route) Sales Quantity by Region (2019-2024) & (K Pcs)
Table 156. Asia-Pacific Finasteride (Oral Route) Sales Quantity by Region (2025-2030) & (K Pcs)
Table 157. Asia-Pacific Finasteride (Oral Route) Consumption Value by Region (2019-2024) & (USD Million)
Table 158. Asia-Pacific Finasteride (Oral Route) Consumption Value by Region (2025-2030) & (USD Million)
Table 159. South America Finasteride (Oral Route) Sales Quantity by Type (2019-2024) & (K Pcs)
Table 160. South America Finasteride (Oral Route) Sales Quantity by Type (2025-2030) & (K Pcs)
Table 161. South America Finasteride (Oral Route) Sales Quantity by Application (2019-2024) & (K Pcs)
Table 162. South America Finasteride (Oral Route) Sales Quantity by Application (2025-2030) & (K Pcs)
Table 163. South America Finasteride (Oral Route) Sales Quantity by Country (2019-2024) & (K Pcs)
Table 164. South America Finasteride (Oral Route) Sales Quantity by Country (2025-2030) & (K Pcs)
Table 165. South America Finasteride (Oral Route) Consumption Value by Country (2019-2024) & (USD Million)
Table 166. South America Finasteride (Oral Route) Consumption Value by Country (2025-2030) & (USD Million)
Table 167. Middle East & Africa Finasteride (Oral Route) Sales Quantity by Type (2019-2024) & (K Pcs)
Table 168. Middle East & Africa Finasteride (Oral Route) Sales Quantity by Type (2025-2030) & (K Pcs)
Table 169. Middle East & Africa Finasteride (Oral Route) Sales Quantity by Application (2019-2024) & (K Pcs)
Table 170. Middle East & Africa Finasteride (Oral Route) Sales Quantity by Application (2025-2030) & (K Pcs)
Table 171. Middle East & Africa Finasteride (Oral Route) Sales Quantity by Region (2019-2024) & (K Pcs)
Table 172. Middle East & Africa Finasteride (Oral Route) Sales Quantity by Region (2025-2030) & (K Pcs)
Table 173. Middle East & Africa Finasteride (Oral Route) Consumption Value by Region (2019-2024) & (USD Million)
Table 174. Middle East & Africa Finasteride (Oral Route) Consumption Value by Region (2025-2030) & (USD Million)
Table 175. Finasteride (Oral Route) Raw Material
Table 176. Key Manufacturers of Finasteride (Oral Route) Raw Materials
Table 177. Finasteride (Oral Route) Typical Distributors
Table 178. Finasteride (Oral Route) Typical Customers
LIST OF FIGURE
s
Figure 1. Finasteride (Oral Route) Picture
Figure 2. Global Finasteride (Oral Route) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Finasteride (Oral Route) Consumption Value Market Share by Type in 2023
Figure 4. 1mg Examples
Figure 5. 5mg Examples
Figure 6. Global Finasteride (Oral Route) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Finasteride (Oral Route) Consumption Value Market Share by Application in 2023
Figure 8. Urology Examples
Figure 9. Dermatology Examples
Figure 10. Global Finasteride (Oral Route) Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Finasteride (Oral Route) Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Finasteride (Oral Route) Sales Quantity (2019-2030) & (K Pcs)
Figure 13. Global Finasteride (Oral Route) Average Price (2019-2030) & (US$/Pcs)
Figure 14. Global Finasteride (Oral Route) Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Finasteride (Oral Route) Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Finasteride (Oral Route) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Finasteride (Oral Route) Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Finasteride (Oral Route) Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Finasteride (Oral Route) Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Finasteride (Oral Route) Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Finasteride (Oral Route) Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Finasteride (Oral Route) Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Finasteride (Oral Route) Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Finasteride (Oral Route) Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Finasteride (Oral Route) Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Finasteride (Oral Route) Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Finasteride (Oral Route) Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Finasteride (Oral Route) Average Price by Type (2019-2030) & (US$/Pcs)
Figure 29. Global Finasteride (Oral Route) Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Finasteride (Oral Route) Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Finasteride (Oral Route) Average Price by Application (2019-2030) & (US$/Pcs)
Figure 32. North America Finasteride (Oral Route) Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Finasteride (Oral Route) Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Finasteride (Oral Route) Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Finasteride (Oral Route) Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Finasteride (Oral Route) Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Finasteride (Oral Route) Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Finasteride (Oral Route) Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Finasteride (Oral Route) Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Finasteride (Oral Route) Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Finasteride (Oral Route) Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Finasteride (Oral Route) Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Finasteride (Oral Route) Consumption Value Market Share by Region (2019-2030)
Figure 52. China Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Finasteride (Oral Route) Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Finasteride (Oral Route) Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Finasteride (Oral Route) Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Finasteride (Oral Route) Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Finasteride (Oral Route) Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Finasteride (Oral Route) Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Finasteride (Oral Route) Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Finasteride (Oral Route) Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Finasteride (Oral Route) Market Drivers
Figure 73. Finasteride (Oral Route) Market Restraints
Figure 74. Finasteride (Oral Route) Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Finasteride (Oral Route) in 2023
Figure 77. Manufacturing Process Analysis of Finasteride (Oral Route)
Figure 78. Finasteride (Oral Route) Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Table 1. Global Finasteride (Oral Route) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Finasteride (Oral Route) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Finasteride (Oral Route) Product and Services
Table 6. Merck Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Merck Recent Developments/Updates
Table 8. Sandoz Basic Information, Manufacturing Base and Competitors
Table 9. Sandoz Major Business
Table 10. Sandoz Finasteride (Oral Route) Product and Services
Table 11. Sandoz Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Sandoz Recent Developments/Updates
Table 13. Actavis Basic Information, Manufacturing Base and Competitors
Table 14. Actavis Major Business
Table 15. Actavis Finasteride (Oral Route) Product and Services
Table 16. Actavis Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Actavis Recent Developments/Updates
Table 18. Cipla Basic Information, Manufacturing Base and Competitors
Table 19. Cipla Major Business
Table 20. Cipla Finasteride (Oral Route) Product and Services
Table 21. Cipla Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Cipla Recent Developments/Updates
Table 23. RelonChem Basic Information, Manufacturing Base and Competitors
Table 24. RelonChem Major Business
Table 25. RelonChem Finasteride (Oral Route) Product and Services
Table 26. RelonChem Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. RelonChem Recent Developments/Updates
Table 28. Dr. Reddy Basic Information, Manufacturing Base and Competitors
Table 29. Dr. Reddy Major Business
Table 30. Dr. Reddy Finasteride (Oral Route) Product and Services
Table 31. Dr. Reddy Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Dr. Reddy Recent Developments/Updates
Table 33. Accord Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 34. Accord Pharmaceuticals Major Business
Table 35. Accord Pharmaceuticals Finasteride (Oral Route) Product and Services
Table 36. Accord Pharmaceuticals Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Accord Pharmaceuticals Recent Developments/Updates
Table 38. Hangzhou Kangenbei Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 39. Hangzhou Kangenbei Pharmaceutical Co., Ltd Major Business
Table 40. Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 41. Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Hangzhou Kangenbei Pharmaceutical Co., Ltd Recent Developments/Updates
Table 43. Hunan Zhengqing Pharmaceutical Group Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 44. Hunan Zhengqing Pharmaceutical Group Co., Ltd Major Business
Table 45. Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Product and Services
Table 46. Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Hunan Zhengqing Pharmaceutical Group Co., Ltd Recent Developments/Updates
Table 48. Tianfang Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 49. Tianfang Pharmaceutical Co., Ltd Major Business
Table 50. Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 51. Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Tianfang Pharmaceutical Co., Ltd Recent Developments/Updates
Table 53. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 54. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Major Business
Table 55. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 56. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Recent Developments/Updates
Table 58. Zhejiang Xianju Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 59. Zhejiang Xianju Pharmaceutical Co., Ltd Major Business
Table 60. Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 61. Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Zhejiang Xianju Pharmaceutical Co., Ltd Recent Developments/Updates
Table 63. Shanghai Hyundai Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 64. Shanghai Hyundai Pharmaceutical Co., Ltd Major Business
Table 65. Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 66. Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Shanghai Hyundai Pharmaceutical Co., Ltd Recent Developments/Updates
Table 68. Hunan Baicao Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 69. Hunan Baicao Pharmaceutical Co., Ltd Major Business
Table 70. Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 71. Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Hunan Baicao Pharmaceutical Co., Ltd Recent Developments/Updates
Table 73. Guangdong Yishu Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 74. Guangdong Yishu Pharmaceutical Co., Ltd Major Business
Table 75. Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 76. Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Guangdong Yishu Pharmaceutical Co., Ltd Recent Developments/Updates
Table 78. CR SECCO Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 79. CR SECCO Pharmaceutical Co., Ltd Major Business
Table 80. CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 81. CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. CR SECCO Pharmaceutical Co., Ltd Recent Developments/Updates
Table 83. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 84. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Major Business
Table 85. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Product and Services
Table 86. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Recent Developments/Updates
Table 88. Renhetang Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 89. Renhetang Pharmaceutical Company Limited Major Business
Table 90. Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Product and Services
Table 91. Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Renhetang Pharmaceutical Company Limited Recent Developments/Updates
Table 93. Runenberg Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors
Table 94. Runenberg Pharmaceuticals Ltd Major Business
Table 95. Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Product and Services
Table 96. Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. Runenberg Pharmaceuticals Ltd Recent Developments/Updates
Table 98. Nanjing Shenghe Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 99. Nanjing Shenghe Pharmaceutical Co., Ltd Major Business
Table 100. Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 101. Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 102. Nanjing Shenghe Pharmaceutical Co., Ltd Recent Developments/Updates
Table 103. Nanjing Sea Whale Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Nanjing Sea Whale Pharmaceutical Co., Ltd Major Business
Table 105. Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 106. Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales Quantity (K Pcs), Average Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Nanjing Sea Whale Pharmaceutical Co., Ltd Recent Developments/Updates
Table 108. Global Finasteride (Oral Route) Sales Quantity by Manufacturer (2019-2024) & (K Pcs)
Table 109. Global Finasteride (Oral Route) Revenue by Manufacturer (2019-2024) & (USD Million)
Table 110. Global Finasteride (Oral Route) Average Price by Manufacturer (2019-2024) & (US$/Pcs)
Table 111. Market Position of Manufacturers in Finasteride (Oral Route), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 112. Head Office and Finasteride (Oral Route) Production Site of Key Manufacturer
Table 113. Finasteride (Oral Route) Market: Company Product Type Footprint
Table 114. Finasteride (Oral Route) Market: Company Product Application Footprint
Table 115. Finasteride (Oral Route) New Market Entrants and Barriers to Market Entry
Table 116. Finasteride (Oral Route) Mergers, Acquisition, Agreements, and Collaborations
Table 117. Global Finasteride (Oral Route) Sales Quantity by Region (2019-2024) & (K Pcs)
Table 118. Global Finasteride (Oral Route) Sales Quantity by Region (2025-2030) & (K Pcs)
Table 119. Global Finasteride (Oral Route) Consumption Value by Region (2019-2024) & (USD Million)
Table 120. Global Finasteride (Oral Route) Consumption Value by Region (2025-2030) & (USD Million)
Table 121. Global Finasteride (Oral Route) Average Price by Region (2019-2024) & (US$/Pcs)
Table 122. Global Finasteride (Oral Route) Average Price by Region (2025-2030) & (US$/Pcs)
Table 123. Global Finasteride (Oral Route) Sales Quantity by Type (2019-2024) & (K Pcs)
Table 124. Global Finasteride (Oral Route) Sales Quantity by Type (2025-2030) & (K Pcs)
Table 125. Global Finasteride (Oral Route) Consumption Value by Type (2019-2024) & (USD Million)
Table 126. Global Finasteride (Oral Route) Consumption Value by Type (2025-2030) & (USD Million)
Table 127. Global Finasteride (Oral Route) Average Price by Type (2019-2024) & (US$/Pcs)
Table 128. Global Finasteride (Oral Route) Average Price by Type (2025-2030) & (US$/Pcs)
Table 129. Global Finasteride (Oral Route) Sales Quantity by Application (2019-2024) & (K Pcs)
Table 130. Global Finasteride (Oral Route) Sales Quantity by Application (2025-2030) & (K Pcs)
Table 131. Global Finasteride (Oral Route) Consumption Value by Application (2019-2024) & (USD Million)
Table 132. Global Finasteride (Oral Route) Consumption Value by Application (2025-2030) & (USD Million)
Table 133. Global Finasteride (Oral Route) Average Price by Application (2019-2024) & (US$/Pcs)
Table 134. Global Finasteride (Oral Route) Average Price by Application (2025-2030) & (US$/Pcs)
Table 135. North America Finasteride (Oral Route) Sales Quantity by Type (2019-2024) & (K Pcs)
Table 136. North America Finasteride (Oral Route) Sales Quantity by Type (2025-2030) & (K Pcs)
Table 137. North America Finasteride (Oral Route) Sales Quantity by Application (2019-2024) & (K Pcs)
Table 138. North America Finasteride (Oral Route) Sales Quantity by Application (2025-2030) & (K Pcs)
Table 139. North America Finasteride (Oral Route) Sales Quantity by Country (2019-2024) & (K Pcs)
Table 140. North America Finasteride (Oral Route) Sales Quantity by Country (2025-2030) & (K Pcs)
Table 141. North America Finasteride (Oral Route) Consumption Value by Country (2019-2024) & (USD Million)
Table 142. North America Finasteride (Oral Route) Consumption Value by Country (2025-2030) & (USD Million)
Table 143. Europe Finasteride (Oral Route) Sales Quantity by Type (2019-2024) & (K Pcs)
Table 144. Europe Finasteride (Oral Route) Sales Quantity by Type (2025-2030) & (K Pcs)
Table 145. Europe Finasteride (Oral Route) Sales Quantity by Application (2019-2024) & (K Pcs)
Table 146. Europe Finasteride (Oral Route) Sales Quantity by Application (2025-2030) & (K Pcs)
Table 147. Europe Finasteride (Oral Route) Sales Quantity by Country (2019-2024) & (K Pcs)
Table 148. Europe Finasteride (Oral Route) Sales Quantity by Country (2025-2030) & (K Pcs)
Table 149. Europe Finasteride (Oral Route) Consumption Value by Country (2019-2024) & (USD Million)
Table 150. Europe Finasteride (Oral Route) Consumption Value by Country (2025-2030) & (USD Million)
Table 151. Asia-Pacific Finasteride (Oral Route) Sales Quantity by Type (2019-2024) & (K Pcs)
Table 152. Asia-Pacific Finasteride (Oral Route) Sales Quantity by Type (2025-2030) & (K Pcs)
Table 153. Asia-Pacific Finasteride (Oral Route) Sales Quantity by Application (2019-2024) & (K Pcs)
Table 154. Asia-Pacific Finasteride (Oral Route) Sales Quantity by Application (2025-2030) & (K Pcs)
Table 155. Asia-Pacific Finasteride (Oral Route) Sales Quantity by Region (2019-2024) & (K Pcs)
Table 156. Asia-Pacific Finasteride (Oral Route) Sales Quantity by Region (2025-2030) & (K Pcs)
Table 157. Asia-Pacific Finasteride (Oral Route) Consumption Value by Region (2019-2024) & (USD Million)
Table 158. Asia-Pacific Finasteride (Oral Route) Consumption Value by Region (2025-2030) & (USD Million)
Table 159. South America Finasteride (Oral Route) Sales Quantity by Type (2019-2024) & (K Pcs)
Table 160. South America Finasteride (Oral Route) Sales Quantity by Type (2025-2030) & (K Pcs)
Table 161. South America Finasteride (Oral Route) Sales Quantity by Application (2019-2024) & (K Pcs)
Table 162. South America Finasteride (Oral Route) Sales Quantity by Application (2025-2030) & (K Pcs)
Table 163. South America Finasteride (Oral Route) Sales Quantity by Country (2019-2024) & (K Pcs)
Table 164. South America Finasteride (Oral Route) Sales Quantity by Country (2025-2030) & (K Pcs)
Table 165. South America Finasteride (Oral Route) Consumption Value by Country (2019-2024) & (USD Million)
Table 166. South America Finasteride (Oral Route) Consumption Value by Country (2025-2030) & (USD Million)
Table 167. Middle East & Africa Finasteride (Oral Route) Sales Quantity by Type (2019-2024) & (K Pcs)
Table 168. Middle East & Africa Finasteride (Oral Route) Sales Quantity by Type (2025-2030) & (K Pcs)
Table 169. Middle East & Africa Finasteride (Oral Route) Sales Quantity by Application (2019-2024) & (K Pcs)
Table 170. Middle East & Africa Finasteride (Oral Route) Sales Quantity by Application (2025-2030) & (K Pcs)
Table 171. Middle East & Africa Finasteride (Oral Route) Sales Quantity by Region (2019-2024) & (K Pcs)
Table 172. Middle East & Africa Finasteride (Oral Route) Sales Quantity by Region (2025-2030) & (K Pcs)
Table 173. Middle East & Africa Finasteride (Oral Route) Consumption Value by Region (2019-2024) & (USD Million)
Table 174. Middle East & Africa Finasteride (Oral Route) Consumption Value by Region (2025-2030) & (USD Million)
Table 175. Finasteride (Oral Route) Raw Material
Table 176. Key Manufacturers of Finasteride (Oral Route) Raw Materials
Table 177. Finasteride (Oral Route) Typical Distributors
Table 178. Finasteride (Oral Route) Typical Customers
LIST OF FIGURE
s
Figure 1. Finasteride (Oral Route) Picture
Figure 2. Global Finasteride (Oral Route) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Finasteride (Oral Route) Consumption Value Market Share by Type in 2023
Figure 4. 1mg Examples
Figure 5. 5mg Examples
Figure 6. Global Finasteride (Oral Route) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Finasteride (Oral Route) Consumption Value Market Share by Application in 2023
Figure 8. Urology Examples
Figure 9. Dermatology Examples
Figure 10. Global Finasteride (Oral Route) Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Finasteride (Oral Route) Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Finasteride (Oral Route) Sales Quantity (2019-2030) & (K Pcs)
Figure 13. Global Finasteride (Oral Route) Average Price (2019-2030) & (US$/Pcs)
Figure 14. Global Finasteride (Oral Route) Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Finasteride (Oral Route) Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Finasteride (Oral Route) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Finasteride (Oral Route) Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Finasteride (Oral Route) Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Finasteride (Oral Route) Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Finasteride (Oral Route) Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Finasteride (Oral Route) Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Finasteride (Oral Route) Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Finasteride (Oral Route) Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Finasteride (Oral Route) Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Finasteride (Oral Route) Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Finasteride (Oral Route) Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Finasteride (Oral Route) Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Finasteride (Oral Route) Average Price by Type (2019-2030) & (US$/Pcs)
Figure 29. Global Finasteride (Oral Route) Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Finasteride (Oral Route) Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Finasteride (Oral Route) Average Price by Application (2019-2030) & (US$/Pcs)
Figure 32. North America Finasteride (Oral Route) Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Finasteride (Oral Route) Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Finasteride (Oral Route) Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Finasteride (Oral Route) Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Finasteride (Oral Route) Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Finasteride (Oral Route) Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Finasteride (Oral Route) Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Finasteride (Oral Route) Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Finasteride (Oral Route) Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Finasteride (Oral Route) Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Finasteride (Oral Route) Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Finasteride (Oral Route) Consumption Value Market Share by Region (2019-2030)
Figure 52. China Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Finasteride (Oral Route) Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Finasteride (Oral Route) Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Finasteride (Oral Route) Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Finasteride (Oral Route) Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Finasteride (Oral Route) Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Finasteride (Oral Route) Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Finasteride (Oral Route) Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Finasteride (Oral Route) Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Finasteride (Oral Route) Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Finasteride (Oral Route) Market Drivers
Figure 73. Finasteride (Oral Route) Market Restraints
Figure 74. Finasteride (Oral Route) Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Finasteride (Oral Route) in 2023
Figure 77. Manufacturing Process Analysis of Finasteride (Oral Route)
Figure 78. Finasteride (Oral Route) Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
